{"title":"法院2022年11月17日判决书注释，C‑224/20","authors":"Krzysztof Dobieżyński","doi":"10.31743/sp.15132","DOIUrl":null,"url":null,"abstract":"The commented judgment concerns the admissibility of repackaging medicinal products in parallel trade. It was issued in connection with new EU regulations aimed at counteracting the counterfeiting of such products. The Court examined how the regulations in question affect the scope of rights enjoyed by the owners of trademarks affixed to products, as well as the rights of entrepreneurs engaged in parallel trade.","PeriodicalId":22051,"journal":{"name":"Studia Prawnicze KUL","volume":"222 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gloss to the Judgment of the Court of Justice of 17 November 2022, C‑224/20\",\"authors\":\"Krzysztof Dobieżyński\",\"doi\":\"10.31743/sp.15132\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The commented judgment concerns the admissibility of repackaging medicinal products in parallel trade. It was issued in connection with new EU regulations aimed at counteracting the counterfeiting of such products. The Court examined how the regulations in question affect the scope of rights enjoyed by the owners of trademarks affixed to products, as well as the rights of entrepreneurs engaged in parallel trade.\",\"PeriodicalId\":22051,\"journal\":{\"name\":\"Studia Prawnicze KUL\",\"volume\":\"222 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Studia Prawnicze KUL\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31743/sp.15132\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Studia Prawnicze KUL","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31743/sp.15132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Gloss to the Judgment of the Court of Justice of 17 November 2022, C‑224/20
The commented judgment concerns the admissibility of repackaging medicinal products in parallel trade. It was issued in connection with new EU regulations aimed at counteracting the counterfeiting of such products. The Court examined how the regulations in question affect the scope of rights enjoyed by the owners of trademarks affixed to products, as well as the rights of entrepreneurs engaged in parallel trade.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
